doi:10.1016/j.rmed.2017.03.011 10BerkowitzAL, SamuelsMA
Obesity is associated with several health complications, including an increased risk of co-morbidities, including type 2 diabetes, cardiovascular disease, chronic kidney disease (CKD) and metabolic dysfunction-associated steatohepatitis (MASH)
Semaglutide (Wegovy) and liraglutide (Saxenda) are the primary weight loss injections licensed in the UK for weight management, and both list headaches as a recognised adverse effect in their Summary of Product Characteristics (SmPC)
From classic Myers Cocktail to specialized NAD+ infusions, glutathione injections, and high-dose Vitamin C therapy, our comprehensive menu of IV and injection treatments provides solutions for fatigue, dehydration, jet lag, illness recovery, and overall optimization
UK pharmacy and clinical practice, guided by the Specialist Pharmacy Service (SPS), generally discourages the routine use of multi-dose vials and requires that any in-use shelf life and storage conditions follow validated, product-specific data